I-crel meganuclease variants with modified specificity, method of preparation and uses thereof
Abstract
Method of preparing a variant of I-CreI meganuclease having specificity modified cleavage, said method comprising: wherein: ES 2347684 T3 (a) replacing Q44, R68 and / or R70 amino acids, referring to the code pdb access lg9y I-CreI, with an amino acid selected from the group consisting of A, D, e, G, H, K, N, P, Q, R, S, T and Y; (B) selecting the variants of I-CreI meganuclease obtained in step (a) having at least one of the following triplet cleaving profile in reference to R3 positions -5 to -3 in a double-stranded DNA target, corresponding said positions -5 to -3 to R3 of the following formula I: 5'- R1CAAAR2R3R4R'4R'3R'2TTTGR'1, 3 ', R1 is absent or present; and when present represents a nucleic acid fragment comprising nucleotides 1 to 9 corresponding to a random nucleic acid sequence or fragment site directed movement of I-CreI meganuclease situated from position -20 to -12 (from 5 'to 3'), at least R1 corresponding to the -12 position of said site-directed movement, R2 represents doublet ac or ct nucleic acid and corresponds to positions -7 to -6 of said homing site, R3 represents a nucleic acid triplet corresponding to said positions -5 to -3, selected among g, t, cya, except the following triplets: gtc, gcc, gtg, gtt and GCT, R4 represents the nucleic acid doublet gt or tc and corresponds to positions -2 to -1 of said site-directed movement, R.sub.1 is absent or present; and when present represents a nucleic acid fragment comprising nucleotides 1 to 9 corresponding to a random nucleic acid sequence or a fragment of a site directed movement of I-CreI meganuclease located from +12 to +20 position ( 5 'to 3'), R '1 corresponding at least to the +12 position of said site-directed movement, R'2 represents the nucleic acid doublet ag or gt, and corresponds to positions +6 to +7 of the site directed motion, R'3 represents a nucleic acid triplet corresponding to said positions +3 to +5, selected among g, t, cya; R'3 being different from gac, GGC, cac, aac, and agc, when R3 and R'3 are not palindromic, R '4 represents the nucleic acid doublet ga or ac and corresponds to positions +1 to +2 of said site directed motion.
Term
No projected expiry on record.
- Priority
- Filed
- Granted
- Today
29 members in 11 offices
Priority claims3
| Document | Office | Kind | Date |
|---|---|---|---|
| 2005000981 | International Bureau of the World Intellectual Property Organization (WIPO) | W | |
| 2005003083 | International Bureau of the World Intellectual Property Organization (WIPO) | W | |
| 2006001203 | International Bureau of the World Intellectual Property Organization (WIPO) | W |
Members29
| Document | Office | Kind | |
|---|---|---|---|
| AU2006224248A1 | Australia | A1 | |
| CA2600033A1 | Canada | A1 | |
| WO2006097784A1 | World Intellectual Property Organization (WIPO) | A1 | |
| WO2006097853A1 | World Intellectual Property Organization (WIPO) | A1 | |
| WO2006097854A1 | World Intellectual Property Organization (WIPO) | A1 | |
| WO2007034262A1 | World Intellectual Property Organization (WIPO) | A1 | |
| EP1863909A1 | European Patent Office (EPO) | A1 | |
| CN101198694A | China | A | |
| JP2008535484A | Japan | A | |
| US2010021448A1 | United States of America | A1 | |
| EP1863909B1 | European Patent Office (EPO) | B1 | |
| AT466933TThis record | Austria | T | |
| ATE466933T1 | Austria | T1 | |
| DE602006014107D1 | Germany | D1 | |
| DK1863909T3 | Denmark | T3 | |
| ES2347684T3 | Spain | T3 | |
| AU2006224248B2 | Australia | B2 | |
| US7897372B2 | United States of America | B2 | |
| US2011072527A1 | United States of America | A1 | |
| EP2325307A1 | European Patent Office (EPO) | A1 | |
| EP2327771A1 | European Patent Office (EPO) | A1 | |
| EP2327772A1 | European Patent Office (EPO) | A1 | |
| EP2327773A1 | European Patent Office (EPO) | A1 | |
| US2011158974A1 | United States of America | A1 | |
| US2012258537A1 | United States of America | A1 | |
| CN101198694B | China | B | |
| US8715992B2 | United States of America | B2 | |
| EP1863909B2 | European Patent Office (EPO) | B2 | |
| CA2600033C | Canada | C |
1 legal event, as the office reported them to INPADOC
Events
| Event | Code | |
|---|---|---|
| Publication of translation of european patent specificationUEP | UEP |
Numbers
- Application
- 6744673
Titles2
- German
- I-CREI-MEGANUKLEASE-VARIANTEN MIT MODIFIZIERTER SPEZIFITÄT SOWIE VERFAHREN ZU IHRER HERSTELLUNG UND VERWENDUNG
- English
- I-CREI-MEGANUCLEASE VARIANTS WITH MODIFIED SPECIFICITY AND METHOD FOR THEIR PREPARATION AND USE
Classification
- CPC, 6
- C12N9/22
- A61K38/00
- A61K48/00
- A61P31/00
- A61P31/12
- A61P43/00
- IPC, 6
- C12N15 10
- C12N15 55
- C12N15 64
- C12N15 79
- C12N15 90
- C12N9 22